29th September 2022

07.15 BIPOSA Run – meet outside front of Marriott Hotel

08.00    Registration with tea, coffee and pastries at the exhibition and posters

08.50 Welcome and housekeeping – Mr. Richard Harrad, Bristol

09.00 Session VII: Free Papers
Moderated by Miss Vivi Choleva, Cyprus

09.02 Acquired myelinated retinal nerve fibres (MRNF) in craniosynostosis patients with raised intracranial pressure: a case series – A Rodriguez-Martinez (CF), V Panteli (C), Oliver Marmoy (RF), D Thompson (C), R Bowman (C), Great Ormond Street Hospital for Children NHS Foundation Trust

09.15 Incidence of uveitis in proactively managed juvenile idiopathic arthritis – K Szarzanowicz (MS), B Flores-Sanchez (T), B Sharples (MS), D Hawley (C), J Choi (C),

09.28 Non-surgical Interventions for Infantile Nystagmus (IN): a systematic review with narrative synthesis – Y Xiang (MS), Elfadaly D (F), Theodorou M (C), Moorfields Eye Hospital

09.41 It’s how they see, not what they see: Assessing visual function in young children with ASD -T Constable (Op), J M Woodhouse, R F Pilling (C), Cardiff University

09.54 Clinical Assessment, Investigation, Diagnosis, and Initial Management of Paediatric Cerebral Visual Impairment: a review of current practice – R Pilling (P), Louise Allen, (C), R Bowman (C), J Ravenscroft (P), K Saunders (P), C Williams (P), University of Bradford

10.07 Round up by moderator

10.10 Session VIII: Strabismus Surgerychaired by Mr Richard Harrad, Bristol

10.15      Through the keyhole – Mr Saurabh Jain, London

10.40      “From VR to OR” – Mr John Ferris, Cheltenham

11.05      Intramuscular Bupivicaine on purpose – Mr Ian Marsh, Aintree

11.30 Tea, coffee and biscuits at the trade exhibition and posters

12.00 Session IX: Roger Trimble Lecturer introduced by Mr Richard Harrad, Bristol
Congenital Cranial Dysinnervation Disorders
Prof. Elizabeth Engle MD, Boston

13.00 Lunch at the trade exhibition and posters

14.00 Session X: Rapid-fire free paper presentations
Moderated by Miss Saj Amarakoon, Bristol

14.02 Clinical Benefits of Adalimumab in Non-JIA Paediatric Uveitis – I Y M Yip (CL), J Gonzalez-Martin (C), Alder Hey Children’s Hospital

14.09 Abnormal eye movements in infancy- the importance of pattern recognition – S Goyal (FD), M Parulekar (C), R Goyal (C), Royal Glamorgan Hospital – Cwm Taf University Health Board

14.16 A one-year audit of ROP screening using ultrawide- field scanning laser ophthalmoscopy (UwF-SLO) -R Purohit (O), K Xue, S Aslam, C K Patel (C), Oxford Eye Hospital

14.23 Redesign of a tertiary centre paediatric inpatient referral pathway to paediatric ophthalmology – S Khan (T), H Jasim (T), A Dev-Borman (C), Bristol Eye Hospital

14.30 Assessment of an augmented reality low visual aid in children and young people with visual impairment – F Burgum (O), S Gosling (O), E Cottingham (O), L Bird (O), A Tandon (C), J Roehrig (RA), C Bartlett (o), Sheffield Children’s Hospital

14.37 Outcomes of eye screening in visually asymptomatic children with congenital hearing impairment – S Simpson (T), M Nassar (C), A Connor (C), Royal Victoria Infirmary, Newcastle

14.44 Utilising Virtual Clinics and Allied Health Care Professionals to aid COVID-19 recovery in Adult Strabismus services – J Francis (O), M Rhodes (O), J Choi (C), Sheffield Teaching Hospitals NHS Foundation Trust

14.51 Surgical Management of Limbal Epibulbar Dermoid Cysts – R Dodeja (CF), S Biswas (C), Manchester Royal Eye Hospital

14.58 Round up by moderator

14.58 Session XI: Paediatric Uveitis
Chaired by Mr Simon Epps, Bristol

15.00      Making an ‘invisible’ disease visible: developing objective and patient centred disease metrics for childhood uveitis – Ameenat Lola Solebo, London

15.20      MIWGUC – the Multinational Interdisciplinary Working Group for Uveitis in Childhood – Clive Edelston, Oxford

15.40      The UNICORN study – Ameenat Lola Solebo, London


16.00 Tea, coffee and biscuits at the trade exhibition and posters

16.30 Session XII: Paediatric Neuro-ophthalmology
Chaired by Dr Denize Atan, Bristol

16.30    Prevalence of vision and eye movement abnormalities in children referred to a Children’s Epilepsy Surgery Service (CESS) – Claire Chan

16.50    Visual side effects of vigabatrin to treat epilepsy –Andrew Lux, Consultant Paediatric Neurologist, Bristol

17.10     Visual preservation in epilepsy surgery – Mike Carter, Consultant Paediatric Neurosurgeon, Bristol

17.30 Closing remarks by Mr Richard Harrad, Bristol

19.00 Dinner at SS Great Britain, ticketed event

Submit Abstract

Learn More

Register Online

Learn More

Bristol FAQ / info

Learn More

Info on Prizes

Learn More